The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vincristine     Quarter: 2016Q3

Total Records: 1,179     Number of Pages: 59

DRUGNAME PT EventCount
VINCRISTINE SULFATE. Lung infiltration 1
VINCRISTINE SULFATE. Lymphocyte count decreased 1
VINCRISTINE SULFATE. Memory impairment 1
VINCRISTINE SULFATE. Meningitis 1
VINCRISTINE SULFATE. Meningitis bacterial 1
VINCRISTINE SULFATE. Mesenteric venous occlusion 1
VINCRISTINE SULFATE. Metabolic acidosis 1
VINCRISTINE SULFATE. Metapneumovirus infection 1
VINCRISTINE SULFATE. Mobility decreased 1
VINCRISTINE SULFATE. Molluscum contagiosum 1
VINCRISTINE SULFATE. Morganella infection 1
VINCRISTINE SULFATE. Morganella test positive 1
VINCRISTINE SULFATE. Mouth ulceration 1
VINCRISTINE SULFATE. Muscle abscess 1
VINCRISTINE SULFATE. Muscle atrophy 1
VINCRISTINE SULFATE. Muscular weakness 1
VINCRISTINE SULFATE. Musculoskeletal pain 1
VINCRISTINE SULFATE. Mydriasis 1
VINCRISTINE SULFATE. Nasal flaring 1
VINCRISTINE SULFATE. Nasopharyngeal cancer 1

Total Records: 1,179     Number of Pages: 59